Literature DB >> 10843530

Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island.

J D Rich1, B P Dickinson, G Macalino, T P Flanigan, C W Towe, A Spaulding, D Vlahov.   

Abstract

This study explores recent temporal trends in HIV prevalence among women entering prison and the incidence and associated risk factors among women reincarcerated in Rhode Island. Results from mandatory HIV testing from 1992 to 1996 for all incarcerated women were examined. In addition, a case control study was conducted on all seroconverters from 1989 to 1997. In all, 5836 HIV tests were performed on incarceration in 3146 women, 105 of whom tested positive (prevalence, 3.3%). Between 1992 and 1996, the annual prevalence of HIV among all women known to be HIV-positive was stable (p = .12). Age >25 years, nonwhite race, and prior incarceration were associated with seropositivity. Of 1081 initially seronegative women who were retested on reincarceration, 12 seroconverted during 1885 person-years (PY) of follow-up (incidence, 0.6/100 PY). Self-reported injection drug use (IDU; odds ratio [OR], 3.7; 95% confidence interval [CI], 1.3-10.1) was significantly associated with seroconversion, but sexual risk was not (OR, 1.1; 95% CI, 0.4-3.5). Incarceration serves as an opportunity for initiation of treatment and linkage to community services for a population that is at high risk for HIV infection.

Entities:  

Mesh:

Year:  1999        PMID: 10843530     DOI: 10.1097/00126334-199910010-00008

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  22 in total

1.  Successful linkage of medical care and community services for HIV-positive offenders being released from prison.

Authors:  J D Rich; L Holmes; C Salas; G Macalino; D Davis; J Ryczek; T Flanigan
Journal:  J Urban Health       Date:  2001-06       Impact factor: 3.671

2.  Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons.

Authors:  Grace E Macalino; David Vlahov; Stephanie Sanford-Colby; Sarju Patel; Keith Sabin; Christopher Salas; Josiah D Rich
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

3.  From corrections to communities as an HIV priority.

Authors:  David Vlahov; Sara Putnam
Journal:  J Urban Health       Date:  2006-05       Impact factor: 3.671

Review 4.  The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis.

Authors:  Princess A Iroh; Helen Mayo; Ank E Nijhawan
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

5.  Characteristics and trends of newly identified HIV infections among incarcerated populations: CDC HIV voluntary counseling, testing, and referral system, 1992-1998.

Authors:  K M Sabin; R L Frey; R Horsley; S M Greby
Journal:  J Urban Health       Date:  2001-06       Impact factor: 3.671

6.  Assessing criminal justice involvement as an indicator of human immunodeficiency virus risk among women in methadone treatment.

Authors:  Matthew W Epperson; Maria R Khan; Daniel P Miller; Brian E Perron; Nabila El-Bassel; Louisa Gilbert
Journal:  J Subst Abuse Treat       Date:  2010-03-31

7.  Education, empowerment and community based structural reinforcement: an HIV prevention response to mass incarceration and removal.

Authors:  Jeffrey Draine; Laura McTighe; Philippe Bourgois
Journal:  Int J Law Psychiatry       Date:  2011-07-27

8.  Applying classification and regression tree analysis to identify prisoners with high HIV risk behaviors.

Authors:  Linda Frisman; Michael Prendergast; Hsiu-Ju Lin; Eleni Rodis; Lisa Greenwell
Journal:  J Psychoactive Drugs       Date:  2008-12

9.  Incarceration of people living with HIV/AIDS: implications for treatment-as-prevention.

Authors:  M-J Milloy; Julio S G Montaner; Evan Wood
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

10.  Incarceration, African Americans and HIV: advancing a research agenda.

Authors:  Nina Harawa; Adaora Adimora
Journal:  J Natl Med Assoc       Date:  2008-01       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.